VEGFA and B-cell chronic lymphocytic leukemia: To identify protective or risk interactions, a review of the distribution of VEGFA variability in different subgroups of CLL was undertaken and revealed an asymmetric frequency of the ACG+/+ genotypes in patients with different mutational status of the IgVH genes (n = 222).